New York Life Investment Management’s Stride LRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,637
Closed -$355K 1127
2024
Q1
$355K Sell
5,637
-3,196
-36% -$193K ﹤0.01% 1265
2023
Q4
$524K Sell
8,833
-224
-2% -$12.3K 0.01% 809
2023
Q3
$408K Sell
9,057
-1,450
-14% -$59K ﹤0.01% 855
2023
Q2
$391K Sell
10,507
-1,678
-14% -$67.1K ﹤0.01% 1034
2023
Q1
$478K Sell
12,185
-3,431
-22% -$135K 0.01% 938
2022
Q4
$488K Buy
15,616
+1,677
+12% +$61.6K 0.01% 948
2022
Q3
$586K Buy
13,939
+1,103
+9% +$44.4K 0.01% 679
2022
Q2
$524K Buy
+12,836
New +$475K 0.01% 704

Other funds holding LRN

New York Life Investment Management's LRN Position: Q2 2024 in Review

New York Life Investment Management sold out of Stride (LRN) in Q2 2024, closing a stake of 5,637 shares — an estimated $355K sold.

New York Life Investment Management first reported a position in LRN in Q2 2022 and held it in 8 quarters. The position peaked at $586K in Q3 2022. 329 funds tracked by Wall St. Rank hold LRN as of Q2 2024.

  • New York Life Investment Management reported no remaining Stride position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 5,637 Stride shares in Q2 2024, an estimated $355K.
  • New York Life Investment Management first reported a position in Stride in Q2 2022 and held it in 8 quarters.
  • New York Life Investment Management's Stride position peaked at $586K in Q3 2022.
  • 329 funds tracked by Wall St. Rank held Stride as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.